- Home
- REGN vs VLO Comparison
REGN vs VLO Comparison
Compare REGN & VLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REGN | VLO |
|---|---|---|
| Founded | 1988 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.2B | 67.2B |
| IPO Year | 1995 | 1997 |
Fundamental Metrics
Financial Performance| Metric | REGN | VLO |
|---|---|---|
| Price | $638.39 | $256.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 18 |
| Target Price | ★ $830.16 | $232.17 |
| AVG Volume (30 Days) | 1.0M | ★ 2.4M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | 0.55% | ★ 1.91% |
| EPS Growth | ★ 8.19 | N/A |
| EPS | ★ 6.75 | 4.22 |
| Revenue | $5,872,227,000.00 | ★ $122,687,000,000.00 |
| Revenue This Year | $12.45 | $9.62 |
| Revenue Next Year | $10.13 | N/A |
| P/E Ratio | $93.13 | ★ $61.39 |
| Revenue Growth | ★ 20.82 | N/A |
| 52 Week Low | $494.42 | $128.02 |
| 52 Week High | $821.11 | $265.61 |
Technical Indicators
Market Signals| Indicator | REGN | VLO |
|---|---|---|
| Relative Strength Index (RSI) | 42.17 | 56.83 |
| Support Level | $610.60 | $230.24 |
| Resistance Level | $783.87 | $259.23 |
| Average True Range (ATR) | 15.40 | 8.99 |
| MACD | 1.54 | 0.86 |
| Stochastic Oscillator | 80.31 | 72.28 |
Price Performance
Historical ComparisonAbout REGN Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
About VLO Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which can produce 1.2 billion gallons per year of renewable diesel.